블로그
- Aurora™ Fluor 488 Anti-2SC antibody - 0.7mg/mL [CRB2105017_3]_Biosynth - 코아사이언스 Aurora™ Fluor 488 Anti-2SC antibody - 0.7mg/mL Cat.# CRB2105017_3 / Size: 50 ug Specification / MSDS ER chaperones and succination has been shown to have roles in regulatory biology.
- Anti-2SC monoclonal antibody, rabbit [CRB2005019_11]_Biosynth - 코아사이언스 Anti-2SC monoclonal antibody, rabbit Cat.# CRB2005019_11 / Size: 20 ug, 50 ug Specification Succination ER chaperones and succination has been shown to have roles in regulatory biology.
- Antibody–Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor ... systemic PARP and TOP1 inhibitors failed due to dose-limiting myelosuppression. Here, we assess the proof-of-mechanism and c.......
- Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition Abstract and DNA damage repair pathways.
- Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in ... Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in patients with metastatic breast cancer Background HER2-targeted antibody–drug conjugates (ADCs) have revolutionized
- Phase III Trial Results Suggest a New Standard of Care in Metastatic HER2-Positive Breast Cancer HER2-Positive Breast Cancer In the phase III DESTINY-Breast09 trial, first-line treatment with the antibody-drug conjugate fam-trastuzumab deruxtecan-nxki (T-DXd) plus the monoclonal antibody pertuzumab significantly
- [에이프릴바이오] 종목 정리 내용 SAFA(Serum Albumin Half-life Extension Platform) 플랫폼과, 이를 업그레이드하여 다중 타깃 약물 개발이 가능한 REMAP(Recombinant and Evolved Multi-specific Antibody Proteins) 플랫폼입니다.
- 고형암 치료에 있어 우리가 주목해야 할 ADC 항암제 Antibody-drug-conjugates (ADCs) combine chemotherapy and targeted therapy to treat certain blood cancers and cancerous tumors.
- <2023.05.30 화요일> 주식 일정 Summit (European Association for the Study of the Liver) 4) 05.07 ~ 10 : TIDES US (Oligoneucleotide and therapeutics) 5) 05.13 ~ 16 : World ADC London 6) 05.15 ~ 19 : PEGS Boston Summit (Protein & Antibody
- <2023.04.30 일요일> 주식 일정 Summit (European Association for the Study of the Liver) 4) 05.07 ~ 10 : TIDES US (Oligoneucleotide and therapeutics) 5) 05.13 ~ 16 : World ADC London 6) 05.15 ~ 19 : PEGS Boston Summit (Protein & Antibody